By almost any standard, Alcon, the global eyecare company with manufacturing and research facilities in Berks County, had a ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY® Vitreoretinal Cataract System ...

Combined vitreoretinal-cataract system (VCS) is cleared for use in Canada New, proprietary technology is designed to deliver significant surgical and workflow efficiencies First innovation to be ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Alcon’s Unity combined vitreoretinal cataract system and stand-alone ...

Alcon (ALC) stock drops 10% after Q1 revenue miss; see earnings details, margin pressure, FY26 outlook and $1.5B buyback—read the key takeaways now.

Please provide your email address to receive an email when new articles are posted on . The Unity platform consists of a vitreoretinal cataract system and a stand-alone cataract system. It improves ...

Q1 2026 Management View "The first quarter was an important step forward for our new products, demonstrating strong market acceptance and share gains" (CEO & Director David Endicott), adding that ...

First-quarter 2026 sales of $2.7 billion, up 10% on a reported basis, or up 6% constant currency1 (cc), versus first-quarter 2025 First-quarter 2026 diluted EPS of $0.39; core diluted EPS2 ...

“Today marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment solutions in cataract and vitreoretinal surgery, and we are grateful to those who helped us ...